{"version":"1.0","provider_name":"KFF","provider_url":"https:\/\/www.kff.org","author_name":"kffaeronw","author_url":"https:\/\/www.kff.org\/author\/kffaeronw\/","title":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kC0iFKXEjQ\"><a href=\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\">President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/embed\/#?secret=kC0iFKXEjQ\" width=\"600\" height=\"338\" title=\"&#8220;President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing&#8221; &#8212; KFF\" data-secret=\"kC0iFKXEjQ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png","thumbnail_width":1920,"thumbnail_height":1080,"description":"While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law."}